Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Shougang Group Releases 2022 Annual Sustainability Report
On September 12th, Shougang released "2022 Annual Sustainability Report for Beijing Shougang Corporation Limited." This report provides a comprehensive overview of Shougang's management, initiatives, and achievements in social responsibility, environmental protection, and corporate governance for the year 2022, focusing on four key aspects: governance foundation, environmental leadership, promoting a better society, and fulfilling their mission.
Sep 18, 2023 10:58 PM
Pharmaceutical Machine Vision Company aocheng Nets Tens of Millions in Round A
EqualOcean has learned that aocheng (Chinese: 奥乘智能), a machine vision inspection company in the pharmaceutical field, has recently closed tens of millions of CNY in round A financing.
Sep 18, 2023 11:55 AM
The Development of China's New Generation Information Technology
Sep 21, 2023 11:46 PM
An Entrepreneur and Her New Journey to Globalization
Sep 21, 2023 05:40 PM
EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part I）
Sep 21, 2023 04:43 PM
Robooter: Structuring New Ecology for Elderly Care
Sep 20, 2023 06:17 PM